Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1610

1.

Testosterone and androstenedione are endogenous substrates of P-glycoprotein.

Yano K, Seto S, Kamioka H, Mizoi K, Ogihara T.

Biochem Biophys Res Commun. 2019 Nov 26;520(1):166-170. doi: 10.1016/j.bbrc.2019.09.067. Epub 2019 Oct 1.

PMID:
31585733
2.

Development of a Geriatric Prognostic Scoring System for Predicting Survival After Surgery for Elderly Patients With Gastrointestinal Cancer.

Yamasaki M, Maekawa Y, Sugimoto K, Mizushima T, Eguchi H, Ogihara T, Shintani A, Rakugi H, Mori M, Doki Y.

Ann Surg Oncol. 2019 Oct;26(11):3644-3651. doi: 10.1245/s10434-019-07687-z. Epub 2019 Aug 6.

PMID:
31388777
3.

Structure-activity relationship of atorvastatin derivatives for metabolic activation by hydrolases.

Mizoi K, Takahashi M, Sakai S, Ogihara T, Haba M, Hosokawa M.

Xenobiotica. 2019 Jun 19:1-9. doi: 10.1080/00498254.2019.1625083. [Epub ahead of print]

PMID:
31173561
4.

[Further investigation of 3D culture spheroid models of human hepatocytes].

Ogihara T, Hosono M, Kojima H.

Nihon Yakurigaku Zasshi. 2019;153(5):235-241. doi: 10.1254/fpj.153.235. Japanese.

PMID:
31092757
5.

The Effect of Viscosity on the Diffusion and Termination Reaction of Organic Radical Pairs.

Li X, Ogihara T, Abe M, Nakamura Y, Yamago S.

Chemistry. 2019 Jul 25;25(42):9846-9850. doi: 10.1002/chem.201902074. Epub 2019 Jul 1.

PMID:
31087699
6.

Reduction Effect of Calcium Alginate on Blood Triglyceride Levels Causing the Inhibition of Hepatic and Total Body Accumulation of Fat in Rats.

Kasahara F, Kato T, Idota Y, Takahashi H, Kakinuma C, Yano K, Arakawa H, Hara K, Miyajima C, Ogihara T.

Biol Pharm Bull. 2019;42(3):365-372. doi: 10.1248/bpb.b18-00530.

7.

Postprandial Plasma Glucagon Kinetics in Type 2 Diabetes Mellitus: Comparison of Immunoassay and Mass Spectrometry.

Katahira T, Kanazawa A, Shinohara M, Koshibu M, Kaga H, Mita T, Tosaka Y, Komiya K, Miyatsuka T, Ikeda F, Azuma K, Takayanagi N, Ogihara T, Ohmura C, Miyachi A, Mieno E, Yamashita S, Watada H.

J Endocr Soc. 2018 Oct 26;3(1):42-51. doi: 10.1210/js.2018-00142. eCollection 2019 Jan 1.

8.

Beneficial effect of laughter therapy on physiological and psychological function in elders.

Yoshikawa Y, Ohmaki E, Kawahata H, Maekawa Y, Ogihara T, Morishita R, Aoki M.

Nurs Open. 2018 Jul 18;6(1):93-99. doi: 10.1002/nop2.190. eCollection 2019 Jan.

9.

Combination Metabolomics Approach for Identifying Endogenous Substrates of Carnitine/Organic Cation Transporter OCTN1.

Masuo Y, Ohba Y, Yamada K, Al-Shammari AH, Seba N, Nakamichi N, Ogihara T, Kunishima M, Kato Y.

Pharm Res. 2018 Oct 2;35(11):224. doi: 10.1007/s11095-018-2507-1.

PMID:
30280275
10.

Successful remission of ulcerative colitis flare-up during pregnancy with adsorptive granulomonocytapheresis plus tacrolimus.

Shibuya T, Haga K, Kamei M, Okahara K, Ito S, Takahashi M, Nomura O, Murakami T, Makino M, Kodani T, Ishikawa D, Sakamoto N, Osada T, Ogihara T, Watanabe S, Nagahara A.

Intest Res. 2018 Jul;16(3):484-488. doi: 10.5217/ir.2018.16.3.484. Epub 2018 Jul 27.

11.

Entinostat reverses P-glycoprotein activation in snail-overexpressing adenocarcinoma HCC827 cells.

Tomono T, Machida T, Kamioka H, Shibasaki Y, Yano K, Ogihara T.

PLoS One. 2018 Jul 6;13(7):e0200015. doi: 10.1371/journal.pone.0200015. eCollection 2018.

12.

Intestinal secretion of indoxyl sulfate as a possible compensatory excretion pathway in chronic kidney disease.

Morimoto K, Tominaga Y, Agatsuma Y, Miyamoto M, Kashiwagura S, Takahashi A, Sano Y, Yano K, Kakinuma C, Ogihara T, Tomita M.

Biopharm Drug Dispos. 2018 Jul;39(7):328-334. doi: 10.1002/bdd.2149. Epub 2018 Aug 13.

PMID:
29975986
13.

Randomized, Double-Blind, Crossover Clinical Trial of the Effect of Calcium Alginate in Noodles on Postprandial Blood Glucose Level.

Kato T, Idota Y, Shiragami K, Koike M, Nishibori F, Tomokane M, Seki T, Itabashi K, Hakoda K, Takahashi H, Yano K, Kobayashi T, Obara N, Ogihara T.

Biol Pharm Bull. 2018 Sep 1;41(9):1367-1371. doi: 10.1248/bpb.b18-00156. Epub 2018 Jul 4.

14.

Mechanism of Suppression of Blood Glucose Level by Calcium Alginate in Rats.

Idota Y, Kato T, Shiragami K, Koike M, Yokoyama A, Takahashi H, Yano K, Ogihara T.

Biol Pharm Bull. 2018 Sep 1;41(9):1362-1366. doi: 10.1248/bpb.b18-00155. Epub 2018 Jul 4.

15.

A Case of Fundus Oculi Albinoticus Diagnosed as Angelman Syndrome by Genetic Testing.

Fukiyama Y, Tonari M, Matsuo J, Oku H, Sugasawa J, Shimakawa S, Ogihara T, Okamoto N, Ikeda T.

Case Rep Ophthalmol. 2018 Feb 1;9(1):102-107. doi: 10.1159/000485964. eCollection 2018 Jan-Apr.

16.

Enhanced Expression of the Key Mitosis Regulator Cyclin B1 Is Mediated by PDZ-Binding Kinase in Islets of Pregnant Mice.

Uesato T, Ogihara T, Hara A, Iida H, Miyatsuka T, Fujitani Y, Takeda S, Watada H.

J Endocr Soc. 2018 Jan 30;2(3):207-219. doi: 10.1210/js.2017-00338. eCollection 2018 Mar 1.

17.

Evaluation of the metabolic capability of primary human hepatocytes in three-dimensional cultures on microstructural plates.

Koyama S, Arakawa H, Itoh M, Masuda N, Yano K, Kojima H, Ogihara T.

Biopharm Drug Dispos. 2018 Apr;39(4):187-195. doi: 10.1002/bdd.2125. Epub 2018 Mar 13.

PMID:
29469947
18.

Efficacy and Acceptability of 1 Liter of Polyethylene Glycol with Ascorbic Acid vs. 2 Liters of Polyethylene Glycol Plus Mosapride and Sennoside for Colonoscopy Preparation.

Kamei M, Shibuya T, Takahashi M, Makino M, Haga K, Nomura O, Murakami T, Ritsuno H, Ueyama H, Kodani T, Ishikawa D, Matsumoto K, Sakamoto N, Osada T, Ogihara T, Watanabe S, Nagahara A.

Med Sci Monit. 2018 Jan 26;24:523-530.

19.

Advances in Studies of P-Glycoprotein and Its Expression Regulators.

Yano K, Tomono T, Ogihara T.

Biol Pharm Bull. 2018;41(1):11-19. doi: 10.1248/bpb.b17-00725. Review.

20.

One year follow-up after a randomized controlled trial of a 130 g/day low-carbohydrate diet in patients with type 2 diabetes mellitus and poor glycemic control.

Sato J, Kanazawa A, Hatae C, Makita S, Komiya K, Shimizu T, Ikeda F, Tamura Y, Ogihara T, Mita T, Goto H, Uchida T, Miyatsuka T, Ohmura C, Watanabe T, Kobayashi K, Miura Y, Iwaoka M, Hirashima N, Watada H.

PLoS One. 2017 Dec 4;12(12):e0188892. doi: 10.1371/journal.pone.0188892. eCollection 2017.

21.

Safety and efficacy of metformin up-titration in Japanese patients with type 2 diabetes mellitus treated with vildagliptin and low-dose metformin.

Suzuki L, Kanazawa A, Uzawa H, Osonoi Y, Masuyama A, Azuma K, Takeno K, Takayanagi N, Sato J, Someya Y, Komiya K, Goto H, Mita T, Ikeda F, Ogihara T, Shimizu T, Ohmura C, Saito M, Osonoi T, Watada H.

Expert Opin Pharmacother. 2017 Dec;18(18):1921-1928. doi: 10.1080/14656566.2017.1404576. Epub 2017 Nov 15.

PMID:
29141460
22.

Normal pancreatic β-cell function in mice with RIP-Cre-mediated inactivation of p62/SQSTM1.

Honda A, Komiya K, Hara A, Fukunaka A, Suzuki L, Miyatsuka T, Ogihara T, Fujitani Y, Watada H.

Endocr J. 2018 Jan 30;65(1):83-89. doi: 10.1507/endocrj.EJ17-0333. Epub 2017 Oct 4.

23.

Effects of Calcium-Channel Blocker Benidipine-Based Combination Therapy on Cardiac Events - Subanalysis of the COPE Trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Shimada K, Kawana M, Kario K, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group.

Circ J. 2018 Jan 25;82(2):457-463. doi: 10.1253/circj.CJ-17-0592. Epub 2017 Sep 2.

24.

Successful Readministration of Clozapine in a Patient With a History of Clozapine-Induced Elevation of Creatine Phosphokinase.

Takahashi Y, Ogihara T, Sasayama D, Washizuka S.

Prim Care Companion CNS Disord. 2017 Aug 10;19(4). pii: 16l02084. doi: 10.4088/PCC.16l02084. No abstract available.

25.

Taxanes and platinum derivatives impair Schwann cells via distinct mechanisms.

Imai S, Koyanagi M, Azimi Z, Nakazato Y, Matsumoto M, Ogihara T, Yonezawa A, Omura T, Nakagawa S, Wakatsuki S, Araki T, Kaneko S, Nakagawa T, Matsubara K.

Sci Rep. 2017 Jul 20;7(1):5947. doi: 10.1038/s41598-017-05784-1.

26.

Utility of human hepatocyte spheroids without feeder cells for evaluation of hepatotoxicity.

Ogihara T, Arakawa H, Jomura T, Idota Y, Koyama S, Yano K, Kojima H.

J Toxicol Sci. 2017;42(4):499-507. doi: 10.2131/jts.42.499.

27.

Preliminary Evaluation of Three-Dimensional Primary Human Hepatocyte Culture System for Assay of Drug-Metabolizing Enzyme-Inducing Potential.

Arakawa H, Kamioka H, Jomura T, Koyama S, Idota Y, Yano K, Kojima H, Ogihara T.

Biol Pharm Bull. 2017;40(7):967-974. doi: 10.1248/bpb.b16-00885.

28.

Efficacy of cytapheresis for remission induction and dermatological manifestations of ulcerative colitis.

Nomura O, Osada T, Shibuya T, Ishikawa D, Haga K, Kodani T, Sakamoto N, Ogihara T, Yamaji K, Watanabe S.

J Clin Apher. 2018 Feb;33(1):21-28. doi: 10.1002/jca.21555. Epub 2017 Jun 5.

PMID:
28581039
29.

Gastrointestinal Hormone Cholecystokinin Increases P-Glycoprotein Membrane Localization and Transport Activity in Caco-2 Cells.

Yano K, Shimizu S, Tomono T, Ogihara T.

J Pharm Sci. 2017 Sep;106(9):2650-2656. doi: 10.1016/j.xphs.2017.04.003. Epub 2017 Apr 12.

PMID:
28411043
30.

Determination of the Absolute Configuration of a Monoglyceride Antibolting Compound and Isolation of Related Compounds from Radish Leaves (Raphanus sativus).

Ogihara T, Amano N, Mitsui Y, Fujino K, Ohta H, Takahashi K, Matsuura H.

J Nat Prod. 2017 Apr 28;80(4):872-878. doi: 10.1021/acs.jnatprod.6b00746. Epub 2017 Mar 23.

PMID:
28333463
31.

Snail-Induced Epithelial-to-Mesenchymal Transition Enhances P-gp-Mediated Multidrug Resistance in HCC827 Cells.

Tomono T, Yano K, Ogihara T.

J Pharm Sci. 2017 Sep;106(9):2642-2649. doi: 10.1016/j.xphs.2017.03.011. Epub 2017 Mar 18.

PMID:
28322937
32.

Relationships between lifestyle patterns and cardio-renal-metabolic parameters in patients with type 2 diabetes mellitus: A cross-sectional study.

Ogihara T, Mita T, Osonoi Y, Osonoi T, Saito M, Tamasawa A, Nakayama S, Someya Y, Ishida H, Gosho M, Kanazawa A, Watada H.

PLoS One. 2017 Mar 8;12(3):e0173540. doi: 10.1371/journal.pone.0173540. eCollection 2017.

33.

Efficacy and Safety of Vildagliptin as an Add-On Therapy in Inadequately Controlled Type 2 Diabetes Patients Treated With Basal Insulin.

Saito D, Kanazawa A, Shigihara N, Sato F, Uchida T, Sato J, Goto H, Miyatsuka T, Ikeda F, Ogihara T, Ohmura C, Watada H.

J Clin Med Res. 2017 Mar;9(3):193-199. doi: 10.14740/jocmr2874w. Epub 2017 Jan 25.

34.

[Prevention of Postoperative Delirium and Agitation in a Patient with Anti-NMDA Receptor Encephalitis: A Case Report].

Ogihara T, Serita R, Kaneda T, Koshika K, Ouchi T, Koitabashi T.

Masui. 2017 Feb;66(2):180-183. Japanese.

PMID:
30380285
35.

On-Treatment Blood Pressure and Cardiovascular Outcomes in Older Adults With Isolated Systolic Hypertension.

Yano Y, Rakugi H, Bakris GL, Lloyd-Jones DM, Oparil S, Saruta T, Shimada K, Matsuoka H, Imai Y, Ogihara T.

Hypertension. 2017 Feb;69(2):220-227. doi: 10.1161/HYPERTENSIONAHA.116.08600. Epub 2017 Jan 3.

PMID:
28049699
36.

Effects of calcium channel blocker benidipine-based combination therapy on target blood pressure control and cardiovascular outcome: a sub-analysis of the COPE trial.

Umemoto S, Ogihara T, Matsuzaki M, Rakugi H, Ohashi Y, Saruta T; Combination Therapy of Hypertension to Prevent Cardiovascular Events (COPE) Trial Group.

Hypertens Res. 2017 Apr;40(4):376-384. doi: 10.1038/hr.2016.158. Epub 2016 Dec 1.

37.

Control of the Termination Mechanism in Radical Polymerization by Viscosity: Selective Disproportionation in Viscous Media.

Nakamura Y, Ogihara T, Hatano S, Abe M, Yamago S.

Chemistry. 2017 Jan 26;23(6):1299-1305. doi: 10.1002/chem.201604659. Epub 2016 Dec 1.

PMID:
27859819
38.

Continuation of antithrombotic therapy may be associated with a high incidence of colonic post-polypectomy bleeding.

Shibuya T, Nomura O, Kodani T, Murakami T, Fukushima H, Tajima Y, Matsumoto K, Ritsuno H, Ueyama H, Inami Y, Ishikawa D, Matsumoto K, Sakamoto N, Osada T, Nagahara A, Ogihara T, Watanabe S.

Dig Endosc. 2017 May;29(3):314-321. doi: 10.1111/den.12760. Epub 2016 Nov 23.

PMID:
27809364
39.

Relationship between Physical Parameters of Various Metal Ions and Binding Affinity for Alginate.

Idota Y, Kogure Y, Kato T, Yano K, Arakawa H, Miyajima C, Kasahara F, Ogihara T.

Biol Pharm Bull. 2016;39(11):1893-1896.

40.

A Case of Hydranencephaly in Which Ophthalmic Examinations Were Performed.

Eda S, Terai T, Nishikawa Y, Tonari M, Kida T, Oku H, Sugasawa J, Shimakawa S, Hasegawa M, Ogihara T, Ikeda T.

Case Rep Ophthalmol. 2016 Sep 16;7(3):142-147. eCollection 2016 Sep-Dec.

41.

Effect of hydrochlorothiazide in addition to telmisartan/amlodipine combination for treating hypertensive patients uncontrolled with telmisartan/amlodipine: a randomized, double-blind study.

Higaki J, Komuro I, Shiki K, Lee G, Taniguchi A, Ikeda H, Kuroki D, Nishimura S, Ogihara T.

Hypertens Res. 2017 Mar;40(3):251-258. doi: 10.1038/hr.2016.124. Epub 2016 Oct 20.

42.

Effects of ipragliflozin, a selective sodium-glucose co-transporter 2 inhibitor, on blood pressure in Japanese patients with type 2 diabetes mellitus: a pooled analysis of six randomized, placebo-controlled clinical trials.

Kashiwagi A, Yoshida S, Kawamuki K, Nakamura I, Kazuta K, Ueyama E, Takahashi H, Akiyama N, Kondo Y, Ogihara T.

Diabetol Int. 2016 Sep 9;8(1):76-86. doi: 10.1007/s13340-016-0283-x. eCollection 2017 Mar.

43.

The efficacy and long-term safety of a triple combination of 80 mg telmisartan, 5 mg amlodipine and 12.5 mg hydrochlorothiazide in Japanese patients with essential hypertension: a randomized, double-blind study with open-label extension.

Higaki J, Komuro I, Shiki K, Ugai H, Taniguchi A, Ikeda H, Kuroki D, Nishimura S, Ogihara T.

Hypertens Res. 2017 Jan;40(1):51-60. doi: 10.1038/hr.2016.100. Epub 2016 Sep 1.

44.

A randomized controlled trial of 130 g/day low-carbohydrate diet in type 2 diabetes with poor glycemic control.

Sato J, Kanazawa A, Makita S, Hatae C, Komiya K, Shimizu T, Ikeda F, Tamura Y, Ogihara T, Mita T, Goto H, Uchida T, Miyatsuka T, Takeno K, Shimada S, Ohmura C, Watanabe T, Kobayashi K, Miura Y, Iwaoka M, Hirashima N, Fujitani Y, Watada H.

Clin Nutr. 2017 Aug;36(4):992-1000. doi: 10.1016/j.clnu.2016.07.003. Epub 2016 Jul 18.

PMID:
27472929
45.

Therapeutic effect of intra-articular injection of ribbon-type decoy oligonucleotides for hypoxia inducible factor-1 on joint contracture in an immobilized knee animal model.

Sotobayashi D, Kawahata H, Anada N, Ogihara T, Morishita R, Aoki M.

J Gene Med. 2016 Aug;18(8):180-92. doi: 10.1002/jgm.2891.

PMID:
27352194
46.

Adenovirus vector infection of non-small-cell lung cancer cells is a trigger for multi-drug resistance mediated by P-glycoprotein.

Tomono T, Kajita M, Yano K, Ogihara T.

Biochem Biophys Res Commun. 2016 Aug 5;476(4):183-187. doi: 10.1016/j.bbrc.2016.05.070. Epub 2016 Jun 7.

PMID:
27286705
47.

[Pick's disease].

Yamamoto K, Ogihara T.

Nihon Rinsho. 2016 Mar;74(3):476-81. Japanese.

PMID:
27025090
48.

Closure with clips to accelerate healing of mucosal defects caused by colorectal endoscopic submucosal dissection.

Osada T, Sakamoto N, Ritsuno H, Murakami T, Ueyama H, Matsumoto K, Shibuya T, Ogihara T, Watanabe S.

Surg Endosc. 2016 Oct;30(10):4438-44. doi: 10.1007/s00464-016-4763-7. Epub 2016 Feb 19.

PMID:
26895895
49.

Different regulation of P-glycoprotein function between Caco-2 and Caki-1 cells by ezrin, radixin and moesin proteins.

Yano K, Otsuka K, Kato Y, Kawabata H, Ohmori S, Arakawa H, Ogihara T.

J Pharm Pharmacol. 2016 Mar;68(3):361-7. doi: 10.1111/jphp.12525. Epub 2016 Feb 17.

PMID:
26888084
50.

Interaction of Peptide Transporter 1 With D-Glucose and L-Glutamic Acid; Possible Involvement of Taste Receptors.

Arakawa H, Ohmachi T, Ichiba K, Kamioka H, Tomono T, Kanagawa M, Idota Y, Hatano Y, Yano K, Morimoto K, Ogihara T.

J Pharm Sci. 2016 Jan;105(1):339-42. doi: 10.1016/j.xphs.2015.11.024. Epub 2016 Jan 13.

PMID:
26852864

Supplemental Content

Loading ...
Support Center